Intratumoral treatment with IL-7–CBD + CBD–IL-12 led to a similar extension in survival in mice receiving FTY720 or vehicle control, pointing out that tumor-resident T cells are sufficient to drive the antitumor response. This evidence concerns the gene IL7 and neoplasm.